Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO
|
1 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.700 | 0 | ||||||||
Malignant Neoplasms
|
1641 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.090 | 1.000 | 9 | 2011 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.090 | 1.000 | 9 | 2011 | 2019 | |||||
Endometrial Carcinoma
|
326 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.040 | 1.000 | 4 | 2014 | 2018 | |||||
Malignant neoplasm of endometrium
|
197 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.040 | 1.000 | 4 | 2014 | 2018 | |||||
Liver carcinoma
|
942 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||
Malignant neoplasm of stomach
|
615 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||
Neoplasms
|
1644 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.030 | 1.000 | 3 | 2015 | 2019 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||
Stomach Carcinoma
|
652 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||
Carcinoma of lung
|
1204 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||
cervical cancer
|
268 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Cervix carcinoma
|
283 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Childhood Osteosarcoma
|
151 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 2 | 2014 | 2016 | ||||||
Colorectal Carcinoma
|
1962 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2018 | 2020 | |||||
Malignant neoplasm of lung
|
1142 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||
Malignant neoplasm of prostate
|
1082 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||
Malignant tumor of cervix
|
245 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Osteosarcoma
|
178 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 2 | 2014 | 2016 | ||||||
Osteosarcoma of bone
|
151 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 2 | 2014 | 2016 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||
Prostate carcinoma
|
1168 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Adenocarcinoma of prostate
|
108 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Carcinogenesis
|
355 | 0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 |